LGD-2226
CAS No. 328947-93-9
LGD-2226( LGD2226 )
Catalog No. M14078 CAS No. 328947-93-9
LGD-2226 (LGD2226) is an orally active, selective androgen receptor modulator (SARM) with binding Ki of 1 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLGD-2226
-
NoteResearch use only, not for human use.
-
Brief DescriptionLGD-2226 (LGD2226) is an orally active, selective androgen receptor modulator (SARM) with binding Ki of 1 nM.
-
DescriptionLGD-2226 (LGD2226) is an orally active, selective androgen receptor modulator (SARM) with binding Ki of 1 nM, >1000-fold selectivity over GR,PR, MR and ER; LGD2226 is fully active in cell-based models of bone and muscle, exhibits anabolic activity on muscle and bone with reduced impact on prostate growth in rodent models; LGD2226 is also efficacious in a sex-behavior model in male rats measuring mounts, intromissions, ejaculations, and copulation efficiency.Osteoporosis Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsLGD2226
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorAndrogen Receptor (AR)
-
Research AreaMetabolic Disease
-
IndicationOsteoporosis
Chemical Information
-
CAS Number328947-93-9
-
Formula Weight392.225
-
Molecular FormulaC14H9F9N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1NC2=C(C=C(N(CC(F)(F)F)CC(F)(F)F)C=C2)C(C(F)(F)F)=C1
-
Chemical Name6-(bis-(2,2,2-trifluoroethyl)amino)-4-trifluoromethyl-1H-quinolin-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Miner JN, et al. Endocrinology. 2007 Jan;148(1):363-73.
2. van Oeveren A, et al. J Med Chem. 2006 Oct 19;49(21):6143-6.
molnova catalog
related products
-
SK33
SK33 is a potent and tissue selective anti-androgen agent. SK33 reduces androgen receptor (AR) transcriptional activity.
-
RD162
RD162 is a second-generation, orally available antiandrogen that binds to androgen receptor (AR) with IC50 of 30.9 nM.
-
BMS-641988 B
BMS-641988 is a novel nonsteroidal androgen receptor antagonist for the treatment of prostate cancer.
Cart
sales@molnova.com